| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433143 Tie-2 ligands |
| 08/13/2002 | US6433140 Stable bactericidal permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/13/2002 | US6433018 Method for reducing hypertrophy and ischemia |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/13/2002 | US6433004 Substituted β,γ-anellated lactones |
| 08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432993 Substituted fused heterocyclic compound |
| 08/13/2002 | US6432989 Use of CRF antagonists to treat circadian rhythm disorders |
| 08/13/2002 | US6432978 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one derivatives; cardiovascular, atopic, and rheumatic disorders; antiallergens, antiinflammatory agents, antiasthmatics, and hypotensive agents |
| 08/13/2002 | US6432976 Analgesics; side effect reduction |
| 08/13/2002 | US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 08/13/2002 | US6432972 Desloratadine as non-sedating antihistamine, decongestant |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432957 Piperazine derivative |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432927 Compositions and methods for inducing gene expression |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | US6432687 Polypeptide amino acid sequence with immunoactive segments |
| 08/13/2002 | US6432659 Motor proteins and methods for their use |
| 08/13/2002 | US6432449 Anionic polysaccharides coupled with a metal and a complex leptin protein; biocompatible injections having no side effects |
| 08/12/2002 | WO2001034196A2 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2398832A1 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061998A2 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061109A2 Yeast strains autonomously producing steroids |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061095A1 Novel protein and dna thereof |
| 08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | WO2002061076A1 Adiponectin-associated protein |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/08/2002 | WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060902A1 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060892A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060871A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060485A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
| 08/08/2002 | WO2002060479A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 08/08/2002 | WO2002060465A1 Cholesterol-lowering agent |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060454A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | WO2002060451A1 Method of treating certain eye diseases |
| 08/08/2002 | WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060446A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060439A1 Analgesic and antiinflammatory drugs |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060437A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060432A1 Hypoglycemic agent |
| 08/08/2002 | WO2002060419A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 08/08/2002 | WO2002060389A2 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060387A2 Use of prostaglandin analogs for treatment of cardiac conditions |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002060272A1 Anticholesterolemic edible oil |
| 08/08/2002 | WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 08/08/2002 | WO2002043746A3 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
| 08/08/2002 | WO2002011735A3 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002011665A3 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002007729A9 Non-sedating barbiturate compounds as neuroprotective agents |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002003993A3 Use of inhibitors to multidrug resistance protein 5 (mrp5) to enhance intracellular levels of cyclic nucleotides |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |